We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 3,288 results
  1. A Case of Severe Lead Encephalopathy with Cardiac Arrest Managed During a Chelation Shortage

    Introduction

    For many years, the standard of care in the USA has been to treat acute lead encephalopathy with a combination parenteral dimercaprol...

    Damilola Idowu, Zachary Gray, ... David Gummin in Journal of Medical Toxicology
    Article 16 October 2023
  2. Complement networks in gene-edited pig xenotransplantation: enhancing transplant success and addressing organ shortage

    The shortage of organs for transplantation emphasizes the urgent need for alternative solutions. Xenotransplantation has emerged as a promising...

    Yinglin Yuan, Yuanyuan Cui, ... Gao** Zhao in Journal of Translational Medicine
    Article Open access 02 April 2024
  3. Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel: a reconsideration of premedication protocols in France (PACLIREACT Study)

    Purpose

    An international shortage of ranitidine led to adjustments in premedication regimens for paclitaxel-based chemotherapy in early October 2019....

    Geoffrey Strobbe, Louise Gaboriau, ... Guillaume Marliot in European Journal of Clinical Pharmacology
    Article 13 July 2023
  4. Challenges in Drug Development for Neurological Disorders

    Neurological disorders are the group of pathogen, trauma, or disease induced pathologies that mainly affects our central nervous system, impairing...
    Chapter 2023
  5. AI: Catalyst for Drug Discovery and Development

    This abstract explores the multifaceted roles of AI in expediting the drug development process. AI-driven algorithms analyze vast datasets,...
    Khushbu Nailwal, Sumit Durgapal, ... Tapan Kumar Nailwal in Concepts in Pharmaceutical Biotechnology and Drug Development
    Chapter 2024
  6. Prevalence and factors associated with potential drug-drug interactions in prescriptions presented at private pharmacies in Mbarara city, southwestern Uganda

    Background

    Drug-drug interactions (DDIs) influence the effectiveness of medication and thus determine the treatment outcomes of diseases managed with...

    Allan Phillip Lule, Ogwal Basil Delic, ... Tadele Mekuriya Yadesa in BMC Pharmacology and Toxicology
    Article Open access 02 January 2024
  7. Drug Design Models for Human Diseases by Transgenic Animals

    The procedures of drug research and preclinical trials are difficult, and a significant majority of medication candidates are unable to receive...
    Sabyasachi Banerjee, Subhasis Banerjee, ... Rajendra Gyawali in Concepts in Pharmaceutical Biotechnology and Drug Development
    Chapter 2024
  8. Shortage of aspartate in mitochondria fuels arthritis

    Marc Scherlinger, George C. Tsokos in Nature Immunology
    Article 22 November 2021
  9. Polypharmacology in Old Drug Rediscovery: Drug Repurposing

    The concept of drug repurposing has been introduced in this chapter (Sect. 13.8) as a new strategy for MTD drug discovery based on “promising...
    Zhiguo Wang, Baofeng Yang in Polypharmacology
    Chapter 2022
  10. Estimating the impact of label design on reducing the risk of medication errors by applying HEART in drug administration

    Abstract

    Medication errors are one of the biggest problems in healthcare. The medicines’ poor labelling design (i.e. look-alike labels) is a...

    Carlos Aceves-Gonzalez, Angela Caro-Rojas, ... Karen Hernández-Cruz in European Journal of Clinical Pharmacology
    Article Open access 29 January 2024
  11. Artificial intelligence for natural product drug discovery

    Developments in computational omics technologies have provided new means to access the hidden diversity of natural products, unearthing new potential...

    Michael W. Mullowney, Katherine R. Duncan, ... Marnix H. Medema in Nature Reviews Drug Discovery
    Article 11 September 2023
  12. Management of donations of personal protective equipment in response to the massive shortage during the COVID-19 health crisis: providing quality equipment to health care workers

    Background

    In the COVID-19 pandemic context, a massive shortage of personal protective equipment occurred. To increase the available stocks, several...

    Guillaume Cambien, Jérémy Guihenneuc, ... Sarah Ayraud-Thevenot in Antimicrobial Resistance & Infection Control
    Article Open access 08 November 2021
  13. Develo** a desktop application for drug-drug interaction checker ordered for chronic diseases in Ethiopian hospitals pharmacy

    Background

    Drug-drug interactions are a major cause of morbidity worldwide and are a leading source of treatment inefficacy. They are classified based...

    Thamineni Bheema Lingaiah, Yibeltal Andarge Belay, Kokeb Dese in BMC Pharmacology and Toxicology
    Article Open access 06 June 2022
  14. FDA Approaches in Monitoring Drug Quality, Forces Impacting the Drug Quality, and Recent Alternative Strategies to Assess Quality in the US Drug Supply

    Since the US Food and Drug Administration (FDA) began monitoring the quality of pharmaceutical manufacturing by enforcing current good manufacturing...

    Philip J. Almeter, James T. Isaacs, ... Robert A. Lodder in Journal of Pharmaceutical Innovation
    Article 03 June 2022
  15. Drug-resistant profiles of extracellular vesicles predict therapeutic response in TNBC patients receiving neoadjuvant chemotherapy

    Background

    Predicting tumor responses to neoadjuvant chemotherapy (NAC) is critical for evaluating prognosis and designing treatment strategies for...

    Min Woo Kim, Hyojung Lee, ... Jee Ye Kim in BMC Cancer
    Article Open access 07 February 2024
  16. Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing

    The field of regenerative medicine has witnessed remarkable advancements with the emergence of induced pluripotent stem cells (iPSCs) derived from a...

    **ya Yin, Qingfeng Li, ... Yuanyuan Zhang in Journal of Biomedical Science
    Article Open access 09 May 2024
  17. Costs are a major driver of antibacterial drug prescriptions in Germany: market analysis from 1985 to 2022

    In recent years, several threatening developments regarding antibacterial drugs, such as rising bacterial resistance and delivery bottlenecks, have...

    Lilly Josephine Bindel, Roland Seifert in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 06 June 2024
  18. Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease

    Numerous neurodegenerative conditions, such as Alzheimer’s, Huntington’s, Parkinson’s, amyotrophic lateral sclerosis, and glioblastoma multiform are...

    Shalu Singh, Rahul Shukla in AAPS PharmSciTech
    Article 02 September 2023
  19. Association of statin use with osteoporosis risk: a drug-targeted Mendelian randomization study

    Background

    Hypercholesterolemia and the related inflammatory response promote the development of osteoporosis, but whether targeted interventions are...

    Zhaozhou Ren, Long Zhou in Inflammopharmacology
    Article 16 February 2024
Did you find what you were looking for? Share feedback.